Ligand Pharmaceuticals (LGND)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

116.91

-0.05%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03	FY02	FY01	FY00	FY99	FY98	FY97	FY96	FY95	FY94
Revenue	131.31M	196.25M	277.13M	186.42M	120.28M	251.45M	141.10M	108.97M	71.91M	64.54M	48.97M	31.39M	30.04M	23.54M	38.94M	27.32M	12.89M	140.96M	176.61M	163.51M	141.14M	96.64M	76.34M	48.11M	40.90M	17.70M	51.70M	36.80M	24.50M	13.30M
Cost of Revenue	35.05M	52.83M	62.18M	30.42M	11.35M	6.34M	5.37M	5.57M	5.81M	9.14M	5.73M	3.60M	4.91M	-	15.23M	-	-	22.64M	39.85M	39.80M	31.62M	20.31M	13.95M	1.62M	3.10M	-7.70M	-9.80M	-9.40M	-3.70M	24.70M
Gross Profit	96.27M	143.42M	214.96M	156.00M	108.94M	245.12M	135.74M	103.40M	66.11M	55.40M	43.24M	27.79M	25.13M	23.54M	23.70M	27.32M	12.89M	118.32M	136.76M	123.71M	109.52M	76.33M	62.39M	46.49M	37.80M	25.40M	61.50M	46.20M	28.20M	-11.40M
Operating Income	11.94M	-25.50M	78.89M	8.55M	-5.72M	163.73M	68.08M	43.88M	27.33M	19.63M	14.94M	574.00K	-698.00K	-29.30M	-9.97M	-97.28M	-60.17M	-168.77M	-26.47M	-37.37M	-19.18M	-24.15M	-23.14M	-45.88M	-56.30M	-69.60M	-30.80M	-32.90M	-24.90M	-20.90M
Interest Income	7.71M	2.05M	886.00K	8.08M	28.43M	14.00M	-	-	-	-	-	381.00K	31.00K	440.00K	586.00K	2.16M	8.65M	-	-	-	-	-	-	-	-	-	-	-	-	-
Pretax Income	63.66M	36.01M	47.30M	-10.54M	796.64M	173.33M	57.23M	7.96M	35.33M	11.30M	9.21M	-3.87M	-2.93M	-15.40M	-9.87M	-97.52M	-53.46M	-174.27M	36.34M	-44.91M	-37.46M	-32.60M	-31.50M	-46.71M	-62.00M	-112.60M	-92.10M	-29.20M	-58.70M	-26.40M
Net Income	52.15M	-5.22M	57.14M	-2.98M	629.30M	143.32M	12.56M	-1.64M	257.31M	12.02M	11.42M	-527.00K	10.18M	-12.52M	-1.95M	-98.11M	281.69M	-31.74M	-36.40M	-45.14M	-37.46M	-32.60M	-42.99M	-72.38M	-74.70M	-117.90M	-100.20M	-37.30M	-64.20M	-27.10M
Selling & General & Admin	52.79M	70.06M	57.48M	64.44M	41.88M	37.73M	28.65M	26.62M	24.38M	22.57M	17.98M	16.11M	14.98M	29.72M	15.21M	23.79M	30.41M	248.28M	107.16M	95.88M	61.02M	41.68M	34.43M	34.11M	27.30M	16.60M	10.10M	10.20M	8.00M	7.00M
Research & Development	24.54M	36.08M	69.01M	59.39M	55.91M	27.86M	26.89M	21.22M	13.38M	12.12M	9.27M	10.79M	10.29M	22.07M	39.87M	30.77M	44.62M	41.93M	56.08M	65.20M	67.68M	58.81M	51.10M	51.29M	59.40M	70.70M	72.40M	59.50M	41.40M	-
Other Expenses	7.00M	34.24M	9.57M	23.44M	16.86M	15.79M	12.12M	10.64M	-10.03M	-3.19M	-2.14M	-2.79M	-	-	-	-1.96M	-1.96M	-3.12M	78.05M	62.03M	50.53M	16.69M	-	6.97M	7.40M	7.70M	9.80M	9.40M	3.70M	2.50M
Operating Expenses	84.32M	140.38M	136.06M	147.27M	114.66M	81.39M	67.66M	58.48M	37.76M	34.69M	27.26M	26.90M	25.27M	51.79M	70.32M	52.59M	73.07M	287.09M	163.23M	161.08M	128.70M	100.48M	85.53M	92.37M	94.10M	95.00M	92.30M	79.10M	53.10M	9.50M
Interest Expense	656.00K	1.80M	18.74M	27.42M	35.74M	48.28M	11.40M	12.18M	11.80M	4.86M	2.08M	3.31M	2.51M	58.00K	270.00K	202.00K	735.00K	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-15.23M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	119.37M	193.21M	198.24M	177.69M	126.00M	87.73M	73.03M	64.06M	43.56M	43.83M	32.99M	30.50M	30.18M	51.79M	70.32M	52.59M	73.07M	309.73M	203.08M	200.88M	160.32M	120.79M	99.48M	93.99M	97.20M	87.30M	82.50M	69.70M	49.40M	34.20M
Income Tax	9.84M	41.23M	-10.29M	-7.55M	167.34M	30.01M	44.67M	10.33M	-219.60M	410.00K	374.00K	-1.19M	-13.10M	-2.62M	-7.92M	-55.00K	-18.70M	-38.41M	59.00K	233.00K	18.28M	8.45M	19.86M	26.49M	18.40M	48.30M	69.40M	4.40M	39.30M	6.20M
Shares Outstanding (Basic)	17.30M	16.87M	16.63M	16.18M	19.00M	24.05M	21.03M	20.83M	19.79M	20.42M	20.31M	19.10M	19.66M	19.61M	18.86M	15.92M	16.35M	13.44M	12.34M	12.28M	11.78M	11.52M	9.90M	9.28M	7.86M	6.73M	5.52M	4.80M	3.73M	2.88M
Shares Outstanding (Diluted)	17.76M	16.87M	17.25M	16.18M	19.76M	24.07M	23.48M	20.83M	21.23M	21.43M	20.75M	19.85M	19.71M	19.61M	18.86M	15.92M	16.35M	13.44M	12.34M	12.28M	11.78M	11.52M	9.90M	9.28M	7.86M	6.73M	5.52M	4.80M	3.73M	2.88M
EPS (Basic)	3.02	-0.31	3.44	-0.18	33.13	5.96	0.60	-0.08	13.00	0.59	0.56	-0.03	0.52	-0.64	-0.1	-6.16	17.22	-2.36	-2.95	-3.68	-3.18	-2.83	-4.34	-7.8	-9.51	-17.51	-18.15	-7.78	-17.19	-9.42
EPS (Diluted)	2.94	-0.31	3.31	-0.18	31.85	5.96	0.53	-0.08	12.12	0.56	0.55	-0.03	0.52	-0.64	-0.1	-6.16	17.22	-2.36	-2.95	-3.68	-3.18	-2.83	-4.34	-7.8	-9.51	-17.51	-18.15	-7.78	-17.19	-9.42
EBITDA	101.73M	54.41M	133.16M	69.05M	38.01M	238.30M	81.15M	55.17M	29.96M	23.37M	18.65M	3.94M	1.74M	-13.13M	-6.47M	-96.26M	-50.11M	-61.86M	-26.47M	-18.27M	-59.69M	-35.13M	-16.56M	-38.64M	-54.19M	-65.10M	-21.00M	-23.50M	-21.20M	-18.40M
Depreciation & Amortization	37.41M	43.39M	41.34M	27.97M	43.73M	16.69M	12.52M	11.29M	2.63M	2.66M	2.66M	2.73M	2.79M	2.21M	3.13M	1.05M	2.62M	16.22M	18.71M	15.28M	14.28M	10.47M	6.57M	6.97M	7.40M	7.70M	9.80M	9.40M	3.70M	2.50M